Institut Universitaire du Cancer de Toulouse - Oncopole
Toulouse, 31059, France
Location status: Recruiting
NCT Number: NCT04513444
This phase II, randomized, non-comparative and monocentric study aims to evaluate the interest of medical hypnosis in the management of anxiety in patients who are moderately anxious, anxious or very anxious during their radiotherapy treatment.
45 patients will be randomized into the following arms:
* Arm A (standard): relaxation with music listening during radiotherapy treatment * Arm B (experimental): relaxation with music listening and hypnosis during radiotherapy treatment
For the study each patient will be followed during 2 months.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Phase 2
Toulouse, 31059, France
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 2 months for each patient
Anxiety will be assessed using the STAI-Y questionnaire (Spielberger State-Trait Anxiety Inventory - State Anxiety form).
Time frame: 2 months for each patient
Time frame: 2 months for each patient
Changes in quality of life from baseline will be assessed in the classroom according to the recommendations of the literature (Osoba, JCO).
Contact information is provided by the study sponsor or research team.
Institut Claudius Regaud
Other
Phase II Study Aiming to Evaluate the Interest of Medical Hypnosis in Anxious Patients Treated by Radiotherapy
Acronym: HYPNOMUSE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07489378
Other Solid Tumors, Pediatric Rare Tumors
Bethesda, Maryland, United States
View Trial DetailsNCT05245136
Characteristics Disease, Metastatic Cancer
Augsburg, Bavaria, Germany
View Trial DetailsNCT05907980
Solid Tumor
Houston, Texas, United States
View Trial DetailsNCT06619587
Solid Tumor
La Jolla, California, United States
View Trial Details